Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Molecular Biology, Genetic, and Epigenetics of Prostate Tumor Publisher



Smk Aghamir Seyed Mohammad KAZEM ; Ha Azodian Ghajar Helia AZODIAN ; A Ssamadi ALI ; Zn Tshabalala Zithulele N
Authors

Source: Published:2024


Abstract

This chapter delves into the intricate molecular mechanisms underlying the development and progression of prostate tumors. Prostate cancer remains a significant health concern globally, making a comprehensive understanding of its genetic and epigenetic aspects imperative. This chapter provides a comprehensive overview of the genetic mutations, alterations, and epigenetic modifications that contribute to prostate tumor initiation, growth, and therapeutic responses. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Biomarker Potential of Slc45a3 and Lncpcat14 Expression in Prostate Cancer: A Comparative Analysis of Urine Samples From Men With Prostate Cancer and Benign Prostate Hyperplasia, Translational Research in Urology (2024)
2. Molecular Characterization of Kras, Braf, and Egfr Genes in Cases With Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations, Clinical Laboratory (2015)
3. Prostate Cancer and Pten/Pi3k/Akt/Mtor Signaling, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Nowroozi (3)
Abbas Shakoori farahani (2)
Other Related Docs
4. Translating Preclinical Insights Into Clinical Strategies: Targeting Cancer Stem Cells and Stemness in Prostate Cancer, Pathology, research and practice (2025)
5. Role of Lncrna Pvt1 in the Progression of Urological Cancers: Novel Insights Into Signaling Pathways and Clinical Opportunities, Cellular Signalling (2025)
6. The Relationship Between Klk3 Rs17632542 and Prncr1 Rs16901979 Polymorphisms With Susceptibility to Prostate Cancer, Meta Gene (2019)
7. Cpg Islands Hypermethylatioin the Promoter Region of Gstp1 Gene in Cell-Free Dna As a Noninvasive Biomarker for Detecting Prostate Cancer, Biochemical and Cellular Archives (2016)
8. A Potential Clinical Significance of Dab2ip and Spry2 Transcript Variants in Prostate Cancer, Pathology Research and Practice (2018)
9. Prostate Cancer and Tumor Microenvironment, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)
10. Her2 Gene Amplification in Patients With Prostate Cancer: Evaluating a Cish-Based Method, Oncology Letters (2016)
11. Detection of Loss of Heterozygosity (Loh) Using Circulating Cell-Free Dna (Cfdna) by Fluorescence-Based Multiplex Pcr for Identification of Patients With Prostate Cancer, Applied Immunohistochemistry and Molecular Morphology (2018)
12. Exosomal Noncoding Rnas in Prostate Cancer, Clinica Chimica Acta (2022)
13. The Importance of Personalized Medicine in Urological Cancers, Journal of Diabetes and Metabolic Disorders (2021)
14. Concurrent Down-Regulation of Pten and Nkx3.1 Expression in Iranian Patients With Prostate Cancer, International Braz J Urol (2015)
15. The Potential Diagnostic and Prognostic Value of Circulating Micrornas in the Assessment of Patients With Prostate Cancer: Rational and Progress, Frontiers in Oncology (2022)
16. Essence of Cancer Epigenetic: A Harmonic Art for the Future, Epigenetics Territory and Cancer (2015)
17. The Association of Itgbl1 and Lppr4/Prg1 Expression Profile in Patients With Prostate Cancer History, Advanced Biomedical Research (2025)
18. The Association of Mir-Let 7B and Mir-548 With Pten in Prostate Cancer, Urology Journal (2019)
19. Evaluation Expression Cox-2 in Prostatic Carcinoma by Pcr and Immunohistochemistry and Its Relationship With Gleason Score, Asia Pacific Journal of Cancer Biology (2021)
20. Circulating Tumor Cells and Dnas in Prostate Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)